COMMUNIQUÉS West-GlobeNewswire

HTG Molecular Announces 2nd Amendment to Second Statement of Work with QIAGEN Manchester Limited
20/08/2018
TUCSON, Ariz., Aug. 20, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has [...]
Vericel Announces Appointment of Jonathan Hopper as Chief Medical Officer
20/08/2018
CAMBRIDGE, Mass., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the appointment of [...]
Intra-Cellular Therapies Appoints Dr. Suresh Durgam as Senior Vice President, Late Stage Clinical Development and Medical Affairs
20/08/2018
NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced the [...]
Humanigen Announces Positive Topline Study Results
20/08/2018
Study Demonstrates that GM-CSF Blockade in Combination with Chimeric Antigen Receptor T Cell Therapy (CAR-T) Prevents the Onset and Severity of Neurotoxicity and Cytokine Release Syndrome BURLINGAME, Calif., Aug. 20, [...]
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive-Compulsive Disorder
20/08/2018
BrainsWay’s deep transcranial magnetic stimulation (Deep TMS) system is a best-in-class device designed to maximize electromagnetic stimulation of deep and broad brain regions, helping to launch a new era in brain [...]
Athenex Appoints Randoll Sze as Chief Financial Officer
20/08/2018
BUFFALO, N.Y., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
BioSig Appoints Johnson & Johnson Veteran Amy Scott
20/08/2018
Former Biosense Webster Director of Strategic Partnerships to drive commercial adoption of PURE EP Santa Monica, CA, Aug. 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company [...]
Coherus BioSciences Management to Participate in Two Investor Healthcare Conferences in September
20/08/2018
REDWOOD CITY, Calif., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will participate in two upcoming investor healthcare conferences in September. [...]
Delcath Announces Beginning of Enrollment of Amended Metastatic Ocular Melanoma Registration Trial
20/08/2018
Stanford University Medical Center First Location to Begin Enrollment Under Single Arm Protocol NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused [...]
Transactions under Novozymes’ stock buyback program
20/08/2018
Please read the full announcement in the attached PDF Attachment 2018_50_Stock_Buybackprogram_EN
European Medicines Agency Authorizes Deferral of Paediatric Investigation Plan for Trogarzo™
20/08/2018
MONTREAL, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that the Paediatric Committee of the European Medicines Agency (“EMA”) has accepted to defer the initiation [...]
L’Agence européenne des médicaments autorise le report du plan d’investigation pédiatrique pour Trogarzo(MC)
20/08/2018
MONTRÉAL, 20 août 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd’hui que le comité pédiatrique de l’Agence européenne des médicaments (« AEM ») a accepté de reporter l’ [...]
Trading by management and close relations of management
20/08/2018
Read the full announcement in the attached file Attachment 2018_49_Trading_by_management_EN
Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours
20/08/2018
PRESS RELEASE Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours Study of IMCnyeso in NSCLC, Bladder Cancer, Melanoma and Synovial Sarcoma is the first in GSK collaboration (Oxford, UK [...]
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-106, an Encapsulated Bowel Preparation
20/08/2018
Once granted, the new formulation patent is expected to be valid until at least 2033 RHB-106 is an encapsulated bowel preparation with worldwide rights licensed to Salix Pharmaceuticals RedHill and Salix recently [...]
iKang Announces Shareholders’ Approval of “Going Private” Transaction
20/08/2018
BEIJING, Aug. 20, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]
Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Care Services Business in Massachusetts, U.S.
20/08/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 20, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), is [...]
Novan Announces Promising Clinical Results with SB414
20/08/2018
In the recently completed Phase 1b trial for atopic dermatitis, clinical efficacy measures were highly correlated with critical and disease-relevant biomarker changes suggesting a topical nitric oxide therapeutic has [...]
Syneos Health™ Acquires Kinapse to Further Enhance End-to-End Capabilities
20/08/2018
Addition of Market Leading Advisory and Operational Solutions Provider Increases High-Value Offerings and Expands Operational Scale in Key Growth Markets RALEIGH, N.C., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Syneos Health, [...]

Pages